Levetiracetam Accord (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This interaction reduces neuronal hyper‑excitability and stabilises synaptic transmission, thereby decreasing the likelihood of seizure generation.

The dosage of levetiracetam is individualized by the prescribing clinician based on the patient’s age, renal function, seizure type and response to therapy. The prescriber determines the appropriate strength, frequency and titration schedule.

Safety data for levetiracetam in pregnancy are limited, and the medication is classified as pregnancy category unknown. It should only be used if the potential benefit outweighs any risk. Breastfeeding mothers should discuss possible infant exposure with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with many traditional antiepileptics, levetiracetam has a relatively simple pharmacokinetic profile, minimal protein binding and few drug‑enzyme interactions. It is often chosen for its broad spectrum of activity and lower risk of hepatic metabolism‑related adverse effects.

Store at room temperature below 25 °C in the original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged.

The medication is supplied as an oral formulation and is taken by mouth with or without food, as directed by the prescriber. Tablets should be swallowed whole and not chewed or crushed unless specifically advised.

Serious adverse reactions can include severe skin rashes such as Stevens‑Johnson syndrome, hypersensitivity reactions, suicidal thoughts or behaviors, and rare blood dyscrasias. Patients should seek immediate medical attention if they notice any of these symptoms.

Levetiracetam should not be used by individuals with a known hypersensitivity to levetiracetam or any of its excipients. Caution is advised in patients with severe renal impairment where dose adjustment may be required, and it should be prescribed only after a thorough clinical assessment.